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Abstract: The metabolic response to stress and infection is closely related to the corresponding
requirements of energy and nutrients. On a general level, the response is driven by a complex
endocrine network and related to the nature and severity of the insult. On an individual level,
the effects of nutritional interventions are highly variable and a possible source of complications.
This narrative review aims to discuss the metabolic changes in critically-ill children and the potential
of developing personalized nutritional interventions. Through a literature search strategy, we have
investigated the importance of blood glucose levels, the nutritional aspects of the different phases
of acute stress response, and the reliability of the available tools to assess the energy expenditure.
The dynamics of metabolism during stressful events reveal the difficult balance between risk of
hypo- or hyperglycemia and under- or overfeeding. Within this context, individualized and accurate
measurement of energy expenditure may help in defining the metabolic needs of patients. Given the
variability of the metabolic response in critical conditions, randomized clinical studies in ill children
are needed to evaluate the effect of individualized nutritional intervention on health outcomes.
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1. Introduction
Acute stress conditions, such as sepsis or severe infections, are the major causes of admission
into pediatric intensive care units (PICUs) [1]. The metabolic response to these conditions has precise
pathophysiological mechanisms, clinical consequences, and therapeutic implications. It is divided
into three phases—the acute phase, the stable phase, and the recovery phase—all characterized
by specific neuroendocrine, metabolic, and immunologic modifications [2]. From an evolutionary
perspective, the pathophysiological mechanisms contribute to the maintenance of body homeostasis,
switching nutritional compounds towards different functions and, at a further stage, may facilitate
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recovery [3,4]. For instance, the translocation of amino acids (AAs) from muscle to liver leads to energy
production and facilitates the synthesis of acute-phase proteins [3,5]. On the other hand, the metabolic
response to stress also includes catabolic processes that, in many circumstances, may increase
physiological instability and resource wasting [6]. The over-activation of inflammatory pathways
(e.g., ubiquitin—proteasome system) may cause large protein breakdown, ending with the consumption
of muscle tissues [7–9]. Furthermore, prolonged metabolic imbalance may lead to the development of
abnormal energy expenditure, mitochondrial failure, and multiple cellular dysfunctions up to organs
damage and failure [10]. In addition, infection-induced nutritional deficiencies appear to diminish
immune responsiveness and impair antimicrobial defensive mechanisms, thus making the host more
susceptible to secondary or opportunistic infections [9]. Considering these metabolic alterations and
the risk of hyper- or hypo-metabolism [10], nutritional interventions may be crucial to improving the
response of the host [11]. The aim of this narrative review is to discuss in view of the novel insights:
(1) the pros and cons of a tight glycemic control; (2) the nutritional problems and strategies in the
different phases of acute stress response; and (3) the reliability and limitations of the available tools to
assess energy expenditure.
2. Methods—Literature Search Strategy
Electronic databases (Pubmed, Medline, Embase, Google Scholar, Knowledge Finder) were used
to locate and appraise relevant studies. We carried out the search to identify the articles published
in English on (i) glycemic control, (ii) nutritional interventions in the different acute stress phases,
(iii) the role of the parenteral nutrition and of the immunity-enhancers nutrients and, finally, (iv) the
usefulness of predictive equations and indirect calorimetry use in critically ill children. Relevant articles
published from January 2007 to March 2017 were identified using the following groups of key terms:
“metabolic response” AND “critical illness” AND “infections”; “hyperglycemia” AND “critically
ill children” OR “nutritional status” OR “nutrition” OR “nutritional sciences” AND “critical care”;
OR “hospitalized children” OR “child, hospitalized” “insulin therapy” AND “critically ill children”;
“energy expenditure” AND “critically ill children”; “nutrition” AND “critically ill children” OR
“PICU”. RCT and largest non-RCT studies were considered. In the eligible studies, we focused on
data on infective events (or inflammation status), need of mechanical ventilation, length of PICU stay,
and mortality rate (number of deaths) for the different nutritional approaches.
3. Results
3.1. Hyperglycemia and Glycemic Control in Stress Conditions
Stress hyperglycemia remains an unsolved medical condition. It is usually defined as blood
glucose level >11.1 mmol/L [12]. Its incidence is very high, ranging between 56% and 86%
among patients requiring intensive care [12]. Mechanical ventilation, vasopressor/inotropic infusion,
continuous renal replacement therapy, infections, and long lengths of stay are the main risk factors of
hyperglycemia that are commonly associated with worse outcomes [1].
Several trials have investigated the consequences of glycemic alterations and of their correction,
providing inconclusive results. The effect of targeting age-adjusted normoglycemia with insulin
infusion was investigated in a large prospective, randomized, controlled study including
700 critically-ill pediatric patients. Subjects were randomly assigned to intensive insulin treatment
(to target blood glucose concentrations of 2.8–4.4 mmol/L in infants and 3.9–5.6 mmol/L in children)
or conventional insulin infusion to prevent blood glucose from exceeding 11.9 mmol/L. A significantly
shorter PICU stay was found in the intensively treated group (5.5 days vs. 6.2 days, p = 0.017) [13].
However, among several neurocognitive outcomes analyzed in a four-year follow-up of these children,
only motor coordination (p≤ 0.03) and cognitive flexibility (p = 0.02) were worse in conventional insulin
infusion group [14]. Another study on 97 patients with a median age of two years demonstrated that
hyperglycemia was associated with higher morbidity (e.g., need of mechanical ventilation at 30 days)
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in meningococcal sepsis [15]. Other investigators found significantly reduced number of complications
(e.g., incidence of sepsis) with lower (6.7–7.2 mmol/L) compared to higher (8.3–8.9 mmol/L) glucose
targets in pediatric patients with burns [16].
On the contrary, a large multicenter trial, including more than 1300 critically-ill children randomly
assigned to conventional glycemic control (glucose below 12 mmol/L) or tight glycemic control
(4–7 mmol/L), found that the tight glycemic control had no significant effect on need of mechanical
ventilation and mortality [17]. In this study, however, the upper limit of tight glycemic control
was higher than in previous RCT, reducing the number of patients undergoing insulin treatment.
In “The Heart and Lung Failure–Pediatric Insulin Titration (HALF-PINT)” trial (Clinical Trials
ID: NCT01565941), glycemic control targeted to blood levels between 2.8–4.4 mmol/L in infants
and 3.3–5.6 mmol/L in children was neither associated with lower length of PICU stay nor with
mortality, as compared to levels between 8.3 and 10 mmol/L [18].
It may also be considered that tight glycemic control is difficult to achieve and, very often,
intensive insulin therapy inevitably increases the risk of hypoglycemic episodes [19]. In turn, if severe
and prolonged, low glucose levels may also cause major adverse events. A study investigating the
effects of hypoglycemia found that critically-ill infants spending more than 50% of the time with
lower (4.4–6.1 mmol/L) glucose levels had more frequent complications (e.g., renal failure) than those
with higher (>11.1 mml/L) glucose levels [20]. However, in the Leuven pediatric study, although
hypoglycemia was more common in children on intensive insulin therapy and patients developing
hypoglycemia had a higher risk of death, this association was not significant and it could be explained
by duration of PICU stay [13,14]. Other similar studies showed contrasting results on the association
between hypoglycemia episodes and neurological consequences [21,22].
Randomized clinical trials on glycemic control and nutrition in critically-ill children are reported
in Table 1. As a result of this section, the targets of glycemic control are still debated. Since normoglycemia
is mostly associated with favorable outcomes, in terms of hospital stay and mortality, both hyperglycemia
and hypoglycemia should be adequately prevented or promptly managed. However, the adoption of a
tight glucose range for critically-ill patients is debated [10]. Indeed, currently, there is no recommendation
available on hyperglycemia management provided from pediatric international societies. A “common
sense approach” suggests keeping blood glucose between 7.8 and 10.0 mmol/L [23].
3.2. The Acute Phase: Metabolic Steps and Nutritional Implications
In acute stress conditions, circulating glucose and glycogen stores are rapidly depleted. Hence,
hepatic gluconeogenesis, fatty acid beta-oxidation, and ketogenesis become the primary source
of energy. At a further stage, the energy necessary for the increased gluconeogenesis is provided from
either lactate or proteins and AAs [24]. These physiologic mechanisms are mediated by the insulin
release switch-off followed by a production of glucagon, cortisol, and epinephrine, and activation of the
sympathetic activity. They aim at providing sufficient energy for body metabolism and, among them,
ketone bodies mainly supply central nervous energy requirements. During severe infections increased
levels of inflammatory cytokines (e.g., IL1 and TNF), ACTH, and growth hormone tend to amplify
these pathways and enhance protein breakdown [25–27]. Although these mechanisms are well known,
management of ketosis in acute stress conditions is still challenging. On the one hand, ketone bodies are
organic acids and, therefore, consume bicarbonates leading to blood acidosis and may cause malaise,
nausea, and vomiting [25,28]. On the other hand, the amount of fatty acids resulting from lipolysis may
even exceed energy requirements and glucose supplementation may rapidly lead to hyperglycemia
and hepatic steatosis [24,25]. Yet, no randomized control trial has been conducted so far on different
strategies to manage ketosis in critically-ill children.
Failing to provide adequate amounts of nutrients in the acute phase of stress response also
results in exacerbation of existing nutritional problems in children. Malnutrition and infection
may indeed interact, reinforcing each other even in milder stage of disease [29–31]. Furthermore,
restricted nutritional support may stimulate autophagy, a survival mechanism by which cells break
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down their own damaged components to recycle intracellular nutrients and generate energy during
starvation [32–34]. However, the acute stress response is a complex condition where hypercatabolism and
muscular tissue consumption often cannot be reversed even with increased provision of nutrients (“futile
cycle of nutrients”) [35]. On the other hand, overfeeding, i.e., a caloric intake/resting energy expenditure
(REE) ratio >110% or >120% [36], is associated with increased morbidity (e.g., delayed ventilator weaning),
prolonged hospitalization, and a higher mortality [37]. Overfeeding may also inhibit autophagy, leading
to an increased risk of cell death and organ dysfunction [35]. Being the lower and upper limits of
individual energy requirements unknown in critically-ill children and may largely vary in the acute
phase of stress conditions, a characteristic paradigm of under- and overfeeding is the unpredictable
combination of metabolic and feeding patterns [38].
3.3. Stable and Recovery Phases
During the stable phase, both an early normalization of the catabolic counter-regulatory hormone
levels and an increased effect of anabolic hormones occur, however, proteins continue to be wasted
while fat stores remain relatively intact [39]. During this phase, the risk of muscle atrophy remains high,
especially if this condition lasts several weeks. On the contrary, in the recovery phase, protein synthesis
exceeds protein break down. Nutrition in both these phases should slowly increase to allow recovery
and growth [40]. A recent systematic review and a single-center study in mechanically-ventilated
children calculated a minimum intake of, respectively, 57 and 58 kcal/kg/day to achieve a positive
nitrogen balance [41,42]. In both studies, a protein intake of 1.5 g/kg/day was suggested to
attain nitrogen balance. In these studies, however, no difference was made between the stable and
recovery phases.
3.4. Nutrition: Method of Administration and Immunity-Enhancers Nutrients
It is generally accepted that enteral nutrition is advised in the stable phase and mostly in the
recovery phase. In the acute phase, it may also be of benefit, but its composition and timing of
administration should be cautiously considered [43].
A large RCT, including 1440 patients from three different PICUs, found that early (within 24 h)
parenteral supplementation of AAs was associated with a higher rate of infections and longer PICU
stay [44]. Yet, the heterogeneity of the population and the different glycemic control strategies were
likely to be biased across the participating centers [43,44]. On the contrary, in a retrospective study
of more than 5100 critically-ill children, early enteral nutrition, over the first 48 h of admission,
was associated with a lower mortality rate in those with a PICU length of stay at least 96 h [45].
Many strategies to optimize enteral nutrition have been developed recently. It has been suggested
that an immune-enhancing formula (i.e., giving patients perioperative nutritional supplements with
immunonutritional additives) might improve the general and metabolic conditions in adults with
infection [5]. In particular, the importance of AAs, dietary nucleotides, and lipids in modulating
immune function has been recognized. For instance, the arginine plasma concentrations are strongly
related to the severity of systemic inflammation, being especially low during the acute phase of
critical illness [46]. Dietary supplementation with arginine might have positive effects on immune
function and reparative collagen synthesis [47]. The role of glutamine supplementation is controversial:
experimental work proposed various mechanisms of action, but none of the randomized studies
in early life showed any effect on mortality and only a few showed some effect on inflammatory
response, organ function, and a trend for infection control [47,48]. Briassoulis et al., in a blinded,
randomized, controlled trial, compared nitrogen balance, biochemical indices, antioxidant catalysts,
and clinical outcomes in critically-ill children given an immune-enhancing formula or conventional
early enteral nutrition [49]. In their cohort, immunonutrition had a favorable effect on some biochemical
indices (e.g., natremia) and antioxidant catalysts. However, the mortality rate did not differ between
the two groups [49]. A further single-center, randomized, blinded controlled trial in 38 children
with septic shock, performed by the same group, compared the effect of early enteral feeding using
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immune-enhancing with non-immune-enhancing formulas on cytokines. The study showed that
immune-enhancing nutrition can interfere with the production of interleukin-6, but no evidence was
found regarding the impact on the short-term outcome [50]. Finally, no clinical effect was provided by
the immune-enhancing diet in a study including 40 ventilated children with severe head injury [51].
Overall, the present section suggests that, besides the role of the appropriate timing of the
parenteral and enteral nutrition, some specific nutrients, particularly AAs, may contribute to an
improvement of the immune response. Newer formulations of enteral or parenteral mixtures of AAs
meeting the individual needs of different critically-ill populations should be tested [10].
3.5. Energy Expenditure Assessment
In critically-ill children, measured or calculated REE has been proposed to estimate energy
intake requirements in children [2]. The five most commonly-used REE prediction formulas are:
the World Health Organization (WHO) formula, the Harris–Benedict formula, the Schofield formula
based on weight, the Schofield formula based on weight and height, and the Oxford formula [25].
These formulas have been validated in healthy children. However, they were found inaccurate
in critically-ill children [38,40,52]. In a prospective cohort study, performed in a PICU setting,
standard equations overestimated the energy expenditure and an 83% incidence of overfeeding
with cumulative energy excess of up to 8000 kcal/week was observed [11]. Another prospective study
found that measured energy expenditure (MEE) during critical illness was much lower than the energy
expenditure predicted by formulas [53]. Further studies came to similar conclusions [54,55].
IC has been proposed as a reference method to measure REE. This technique is used to measure
the rate of energy production and substrate oxidation in children, both in clinical and research settings.
The recent clinical guidelines of the American Society for Parenteral and Enteral Nutrition (ASPEN)
for nutritional support of the critically-ill child, suggest that IC measurements should be obtained
in patients with suspected metabolic alterations or malnutrition [6]. A study including 150 patients
found that 72% of PICU patients were candidates for IC accordingly to the ASPEN guidelines [56].
Particularly, authors suggested prioritizing performing IC in patients <2 years of age, malnourished
(underweight/overweight) on admission, or with a PICU stay of >5 days [56].
In recent years, the reliability of ventilator-derived carbon dioxide production (VCO2) equations
was investigated. These simplified methods measure the VCO2 derived from measurements of
exhaled gas volume and carbon dioxide (CO2) concentrations and seem to be a promising tool
when IC is not available or applicable [57]. Recent studies have demonstrated that this technique
is a promising option for the determination of energy requirements in children on mechanical
ventilation [30]. However, since the variability of RQ (respiratory quotient) influences the accuracy of
the EEVCO2 calculation (EE from CO2 measurements), and many of these approaches assume that the
RQ value is a fixed value, the validity of this technique as an alternative to IC is questionable in some
circumstances [57].
Strides have been made to build new, compact metabolic monitors to measure REE in PICU and
to validate them. However, again, there is a wide range of conditions that may compromise their
accuracy. For instance, metabolic monitors’ errors were shown to be significantly affected by oxygen
concentration and minute ventilation and when used during inhaled anesthesia [58].
4. Conclusions
For critically-ill children, the role of nutrition is evolving from a simple supportive function to the
possibility of an effective co-adjuvant therapy. However, the variability of metabolic responses to stress
requires testing the hypothesis of an individualized approach to nutrition in critically-ill children,
since available data are mainly derived from healthy individuals [59]. Additionally, the possible
“intermediary” role of the microbiome should be investigated in future studies in PICUs [59].
Unfortunately, as previously mentioned, in stress conditions, the futile cycle of nutrients may make
most interventions that are effective in healthy subjects useless. Indeed, inconclusive data are
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available in most important issues of critically-ill child nutrition (such as the glycemic control) and
no international recommendation exists for the management of many common problems in their
day-to-day care [10]. The determination of individual macronutrients needed in the various phases of
stress are still more hypothetical than evidence-based. Finally, problems with the current predictive
equations and lack of availability of IC are likely to result in continued under- or overfeeding in many
critically-ill children, with the associated morbidity [60]. New efforts are urgently needed to develop
individualized nutrition strategies and evaluate their effect on relevant health outcomes.
Table 1. Randomized clinical trials on glycemic control and nutrition in critically-ill children.
Authors, years Country Groups Primary Outcomes Results
Vlasselaers et al.
[13] Belgium
Tight glycemic control
(interventional group) n = 700,
conventional glycemic control
(control group) n = 351, age = 0–16
years. Statistical power = 80%
Effect of tight glycemic
control on duration of
PICU stay and
inflammation
PICU stay was shorter (5.5
vs. 6.2 days, p = 0.017) and
C-reactive protein change
after 5 days lower (–9.8
mg/L vs. 9.0 mg/L, p =
0.007) in interventional vs.
control group
Mesotten et al. [14] Belgium
Tight glycemic control
(interventional group) n = 222,
conventional glycemic control
(control group) n = 234, age ≤ 16
years. Statistical power = 80%
Effect of tight glycemic
control on long-term
follow-up of
neuro-cognitive-outcomes
No significant difference
between the two groups was
observed
Jeschke et al. [16] USA
Tight glycemic control
(interventional group) n = 60,
conventional glycemic control
(control group) n = 159, age = 0–16
years. The study was
underpowered
Effect of tight glycemic
control on infectious
events
Sepsis was less frequent (p <
0.05) in interventional than
in control group (8.2% and
22.6% of patients,
respectively)
Macrae et al. [17] England
Tight glycemic control
(interventional group) n = 694,
conventional glycemic control
(control group) n = 675, age = 0–16
years. Statistical power = 80%
Effect of tight glycemic
control on days alive and
free from and free from
mechanical ventilation at
30 days after enrollment
No significant difference
between the two groups was
observed
Agus et al. [18] USA
Tight glycemic control
(interventional group) n = 349,
conventional glycemic control
(control group) n = 360, age = 2
weeks–17 years. Statistical power =
80%
Effect of tight glycemic
control on length of PICU
stay
No significant difference
between the two groups was
observed
Agus et al. [19] USA
Tight glycemic control
(interventional group) n = 490,
conventional glycemic control
(control group) n = 490, age = 0–36
months. Statistical power = 80%
Effect of tight glycemic
control on mortality,
length of PICU stay, and
infectious events
No significant difference
between the two groups was
observed
Sadhwani et al.
[21] USA
Tight glycemic control
(interventional group) n = 121,
conventional glycemic control
(control group) n = 116, age = 0–36
months. Statistical power not
reported
Effect of tight glycemic
control on
neurodevelopment
follow-up
No significant difference
between the two groups was
observed
Vanhorebee et al.
[22] Belgium
Tight glycemic control
(interventional group) n = 349,
conventional glycemic control
(control group) n = 351, age = 0–16
years. Statistical power = 80%
Effect of tight glycemic
control on neurological
injury biomarkers
No significant difference
between the two groups was
observed
Vanhorebee et al.
[44]
Belgium,
Netherlands,
Canada
Early parenteral nutrition
(interventional group) n = 723, late
parenteral nutrition (control group)
n = 717, age = 0–17 years. Statistical
power = 70%
Effect of macronutrients
supplementation timing
on infections, need of
mechanical ventilation,
and length of PICU stay
The early provision of
amino-acids, and not
glucose or lipids, was
associated with worse
outcomes
Briassoulis et al.
[49] Greece
Immunonutrition (interventional
group), n = 25. Conventional enteral
nutrition (control group) n = 25, age
= 8–9.2 years. Statistical power not
reported
Effect of immunonutrition
on biochemical nutritional
markers and hard
outcomes (mortality,
length of PICU stay, and
need of mechanical
ventilation)
Immunonutrition had a
favorable effect on few
nutritional biochemical
markers, but not on hard
outcomes
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Briassoulis et al.
[50] Greece
Immunonutrition (interventional
group), n = 15, conventional enteral
nutrition (control group) n = 15, age
= 6.5–7.9 years. Statistical power not
reported
Effect of immunonutrition
on interleukins in septic
children
IL-6 levels were lower (11.8
vs. 38.3 pg/mL, p < 0.001)
and IL-8 higher (65.4 vs. 21
pg/mL, p < 0.03) in
interventional group
compared with control
group
Briassoulis et al.
[51] Greece
Immunonutrition (interventional
group), n = 20, conventional enteral
nutrition (control group) n = 20, age
= 6–10.5 years. Statistical power not
reported
Effect of immunonutrition
on biochemical nutritional
markers and hard
outcomes (mortality,
length of PICU stay, and
need of mechanical
ventilation) in severe head
injury patients
Except for IL-8 levels and
nitrogen balance, no
difference was observed
between the two groups
PICU, pediatric intensive care unit.
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